Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

HICL Infrastructure delivers 'solid operational performance'

(Sharecast News) - Investment company HICL Infrastructure said on Monday that it had delivered a "solid operational performance" over the five months ended 29 February. HICL said its performance had demonstrated "the resilient nature" of its underlying assets and had put it on track to deliver its target dividend of 8.25p per share for the financial year to 31 March, with cash generation in line with expectations.

The London-listed company noted that its net asset value and valuation approach continues to be well-informed by transaction data points, including its own disposal activity which now spans over £500.0m of assets, across sectors and geographies, all realised at or above their carrying values.

HICL added that the market for high-quality core infrastructure assets remained "in good health", with increasing transaction volumes noted in the period, which continues to "reaffirm market liquidity and the observed disconnect" between public market and private investor valuations for inflation-correlated core infrastructure.

Chairman Mike Bane said: "HICL's high quality portfolio continues to demonstrate its resilience amidst broader macro volatility, supported by significantly accretive asset rotation announced in the period. Effective capital allocation remains crucial, and the board has deployed disposal proceeds to reduce the balance on the company's revolving credit facility, make a highly accretive incremental investment and launch a share buyback programme."

As of 1000 GMT, HICL shares were up 1.02% at 125.06p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Oxford Biomedica confident as it moves away from vaccine era
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.
N Brown chairman Ron McMillan to retire
(Sharecast News) - N Brown said on Monday that chairman Ron McMillan will be retiring and stepping down from the board with effect from 30 April for personal reasons.
McCarthy out, Adshead in as Ultimate Products chair
(Sharecast News) - Ultimate Products, the parent of homeware brands including Salter and Beldray, announced a change in its leadership on Monday, with James 'Jim' McCarthy deciding to step down as non-executive chair from 31 July.
Supermarket Income REIT buys portfolio of Carrefour supermarkets for €75.3m
(Sharecast News) - Supermarket Income REIT said on Monday that it has bought a portfolio of Carrefour supermarkets in France through a sale and leaseback transaction for €75.3m.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.